Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» MAP Pharma gets US patent for methods of achieving rapid relief of migraine and minimizing side effects based upon pharmacokinetic profile
MAP Pharma gets US patent for methods of achieving rapid relief of migraine and minimizing side effects based upon pharmacokinetic profile
MAP Pharma gets US patent for methods of achieving rapid relief of migraine and minimizing side effects based upon pharmacokinetic profile
Submitted by
admin
on August 14, 2011 - 11:32am
Source:
Pharmabiz
News Tags:
MAP Pharmaceuticals
Levadex
migraines
Tempo inhaler
Headline:
MAP Pharma gets US patent for methods of achieving rapid relief of migraine and minimizing side effects based upon pharmacokinetic profile
Do Not Allow Advertisers to Use My Personal information
